Log in to save to my catalogue

Advances in the development of new biomarkers for Alzheimer's disease

Advances in the development of new biomarkers for Alzheimer's disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f56a63ad026244c5a41ddc10feb525cc

Advances in the development of new biomarkers for Alzheimer's disease

About this item

Full title

Advances in the development of new biomarkers for Alzheimer's disease

Publisher

England: BioMed Central Ltd

Journal title

Translational Neurodegeneration, 2022-04, Vol.11 (1), p.25-25, Article 25

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Alzheimer's disease (AD) is a complex, heterogeneous, progressive disease and is the most common type of neurodegenerative dementia. The prevalence of AD is expected to increase as the population ages, placing an additional burden on national healthcare systems. There is a large need for new diagnostic tests that can detect AD at an early stage wit...

Alternative Titles

Full title

Advances in the development of new biomarkers for Alzheimer's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f56a63ad026244c5a41ddc10feb525cc

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f56a63ad026244c5a41ddc10feb525cc

Other Identifiers

ISSN

2047-9158

E-ISSN

2047-9158

DOI

10.1186/s40035-022-00296-z

How to access this item